Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Submitted by
admin
on March 14, 2013 - 11:15am
Source:
Bloomberg
News Tags:
pancreatic cancer
diabetes
Merck
Januvia
Bristol-Myers Squibb
Byetta
Novo Nordisk
Victoza
Headline:
Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Do Not Allow Advertisers to Use My Personal information
